Instituto do Coracao

Quick facts

Phase 3 pipeline

• Ropivacaine 0.2% + Dexamethasone · Anesthesia / Pain Management
  Ropivacaine blocks sodium channels to provide local anesthesia, while dexamethasone reduces inflammation and edema at the injection site.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Instituto do Coracao portfolio CI brief
• Instituto do Coracao pipeline updates RSS